UTHR filings after 2025-12-19: ROTHBLATT MARTINE A's insider sequence beyond the $1.05B headline
ROTHBLATT MARTINE A's UTHR insider record stands at $1.05B cumulative sales (latest filing 2025-12-19); focus on sequence, transaction-code mix, and ownership trend over time.
The headline number ($1.05B cumulative insider sales) is only the starting point for ROTHBLATT MARTINE A in UTHR. The latest filing date of 2025-12-19 is where sequence analysis begins.
Latest Filing Window
| Date | Code | Shares | Price | Est. Value |
|---|---|---|---|---|
| 2025-12-19 | M | 2,000 | N/A | N/A |
| 2025-12-19 | S | 1,500 | $507.61 | $761K |
| 2025-12-19 | S | 500 | $505.45 | $253K |
| 2025-12-19 | M | 2,000 | $120.26 | $241K |
| 2025-12-18 | M | 4,000 | N/A | N/A |
| 2025-12-18 | S | 1,500 | $510.86 | $766K |
| 2025-12-18 | S | 500 | $509.42 | $255K |
| 2025-12-18 | S | 2,000 | $507.24 | $1.0M |
Why Sequence Beats Snapshot
For insider analysis, persistence matters more than a single print. Investors should track cadence and transaction-code composition across consecutive windows.
Ownership Context
Recorded buy/sell history stands at $15.1M vs $1.05B, with 6,305 total transactions and a latest ownership snapshot of 0.
Industry Search Context
Open external reporting for ROTHBLATT MARTINE A + UTHR
Signal Trigger
Escalate from watch to strong signal only if upcoming filings keep reducing residual ownership.
Related Research
Explore all researchPrincipal’s Q4 2025 filing looked slightly weaker on headline AUM, but the internal rotation was more revealing: Brookfield became a top-ten position, Netflix surged, and the fund cut back in parts of real estate. The next filing will show whether that shift keeps going.
Apr 17, 2026
Dodge & Cox’s Q4 2025 filing barely moved on headline AUM, but the underlying changes were more interesting: fresh positions in Brookfield, TransUnion and PDD inside a still-diversified value book. The next filing will show whether those adds were conviction moves or just incremental reshuffling.
Apr 17, 2026
Nuveen’s Q4 2025 filing stayed large-cap and AI-heavy at the top, but the more revealing addition was a sizable fixed-income sleeve through NXUS and NHYB. The next filing will show whether those credit and bond ETFs remain central or fade back out.
Apr 17, 2026
Fisher’s Q4 2025 filing was still packed with mega-cap tech, but the bigger tell was a giant Treasury and investment-grade corporate bond sleeve built through IEF and VCIT. The next filing will show whether that duration bet was tactical or structural.
Apr 17, 2026
AQR’s Q4 2025 filing kept expanding, with AUM rising to $190.63B, 69 new names, and a dramatic Bristol Myers build inside an already broad book. The next filing will show whether the quant giant keeps pressing this expansion or starts normalizing the roster again.
Apr 17, 2026